Next Generation Labs LLC has been granted a Notice of Allowance from China for its Process for The Preparation of (R-S) Synthetic Nicotine - Patent #201580069647.2
SAN DIEGO, March 22, 2021 /PRNewswire-PRWeb/ -- Next Generation Labs LLC ('NGL'), the world's largest manufacturer of S-isomer, R-S isomer and R-isomer synthetic nicotine sold under the federally-registered brand name TFN® is pleased to announce that the Company has just received its Notice of Allowance from the China Patent Office for its process for The Preparation of R-S [Synthetic] Nicotine, Issue number: 201580069647.2.
Since 2014, NGL has been the leading developer of tobacco-free synthetic nicotine for the vaping, oral nicotine and smoking markets. The Company is pleased that its Chinese patent has now been approved, as this will give NGL the ability to better enforce its rights against many of the Chinese vape liquid and device manufacturers who either falsely claim to be directly producing synthetic nicotine for resale, or for use in further manufacturing of vaping devices destined for sale in the United States and South Korean markets - many of which are likely in violation of NGL's intellectual property rights.
Unfortunately, both the US and Korean markets have been inundated with dozens of fake synthetic nicotine products and brands, and many manufacturers have misleadingly labeled bulk pure nicotine, bulk vape liquid mixtures, and vaping and oral nicotine products as made with TFN®. In many instances, the nicotine contained in these products is not synthetic, tobacco-free or non-tobacco, but is in fact derived from tobacco sources.
For almost a decade, NGL has spent considerable effort establishing a strong global intellectual property portfolio that has become distinctive of the Company's goodwill and of the high-quality adult consumers expect of TFN®-branded nicotine. NGL has been taking direct action in the United States (and through its sole South Korean distribution partner NextEra), to limit the misleading claims of unscrupulous sellers of pseudo-synthetic nicotine, and against manufacturers and brand owners who misrepresent that their product contains TFN® branded synthetic non-tobacco-nicotine.
"With the assistance of the Chinese authorities, NGL now intends to fully enforce its rights against many of these so-called synthetic nicotine brands at their point of manufacture, and will take the lead with national customs agencies to limit the flow of fake synthetic nicotine products at trade exit and entry points in China, the US, EU, UK, South Korea, India, Canada, and Australia."
About Next Generation Labs ('NGL'): Since 2014 NGL has been the world's largest manufacturer of S-isomer, R-S isomer and R-isomer synthetic nicotine under the federally-registered brand name TFN®. NGL has helped brand owners develop next generation products using TFN® nicotine that offers smokers and tobacco users a real alternative to combustible tobacco products, as well as true alternatives to tobacco through its creation of a synthetic nicotine that is free of all tobacco. Unlike some other nicotine, NGL's TFN® product is devoid of any tobacco constituents from point of selection of raw material inputs through to the completion of its manufacturing process. NGL's TFN® products are manufactured under strict conditions to meet cGMP, USP and EU standards to achieve a level of 99.97% pure synthetic nicotine.
Media Contact
Sales and Marketing, Next Generation Labs LLC, +1 775-586-8527, [email protected]
NGL Public Relations, +1 973 668 3887, [email protected]
SOURCE Next Generation Labs LLC
News published on and distributed by:
